OGC
PTPI

One68 Global Capital’s Petros Pharmaceuticals PTPI Stock Holding History

One68 Global Capital’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$109K Buy
+100
New +$94.1K 0.22% 99

Other funds holding PTPI

NP
NorthRock Partners Minneapolis, Minnesota $6.2B AUM 15.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

One68 Global Capital's PTPI Position: Q4 2020 in Review

One68 Global Capital opened a new position in Petros Pharmaceuticals (PTPI) in Q4 2020: 100 shares worth $109K. The stake represents 0.22% of the portfolio and ranks #99 among its holdings.

20 funds tracked by Wall St. Rank hold PTPI as of Q4 2020.

  • One68 Global Capital held 100 shares of Petros Pharmaceuticals worth $109K as of Q4 2020.
  • Petros Pharmaceuticals was a new One68 Global Capital position in Q4 2020.
  • Petros Pharmaceuticals made up 0.22% of One68 Global Capital's portfolio in Q4 2020, its #99 holding.
  • 20 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.